Streetbeat News

Price Targets

BEN

Deutsche Bank analyst Brian Bedell has maintained a 'Hold' rating on Franklin Resources (NYSE:BEN) and lowered the price target from $26 to $24.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:42 am

KKR

Deutsche Bank analyst Brian Bedell has maintained a 'Buy' rating on KKR & Co (NYSE:KKR) but lowered the price target from $75 to $72.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:39 am

SNDX

Goldman Sachs analyst Chris Shibutani has initiated coverage on Syndax Pharmaceuticals with a Buy rating and a price target of $30.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:39 am

CG

Deutsche Bank analyst Brian Bedell has maintained a 'Buy' rating on Carlyle Group (NASDAQ:CG) and raised the price target from $43 to $44.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:37 am

BAM

Deutsche Bank analyst Brian Bedell has maintained a 'Hold' rating on Brookfield Asset Management (NYSE:BAM) and lowered the price target from $35 to $34.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:35 am

APO

Deutsche Bank analyst Brian Bedell has maintained a 'Buy' rating on Apollo Global Management (NYSE:APO) and raised the price target from $100 to $102.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:33 am

AMG

Deutsche Bank analyst Brian Bedell has maintained a 'Buy' rating on Affiliated Managers Group (AMG), but lowered the price target from $150 to $148.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:30 am

ALNY

HC Wainwright & Co. analyst Patrick Trucchio maintains a 'Buy' rating on Alnylam Pharmaceuticals (NASDAQ:ALNY), but has lowered the price target from $405 to $395.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:28 am

RICK

HC Wainwright & Co. analyst Scott Buck maintains a 'Buy' rating on RCI Hospitality Hldgs (NASDAQ:RICK) but lowers the price target from $126 to $115.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:25 am

EVCM

JP Morgan analyst Alexei Gogolev has downgraded EverCommerce (NASDAQ:EVCM) from Overweight to Neutral and lowered the price target from $14 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 10:24 am